Key result
Transcatheter aortic valve implantation in a patient with Heyde's syndrome led to the normalization of von Willebrand factor parameters and complete cessation of gastrointestinal bleeding at 1 month.
Why the study?
Heyde syndrome complications can be fatal, and TAVI may represent an alternative to surgical valve replacement in high-risk patients.
Does transcatheter aortic valve implantation (TAVI) resolve gastrointestinal bleeding and improve hemostatic parameters in a patient with Heyde's syndrome?
Case Report (n=1)
No
Does transcatheter aortic valve implantation (TAVI) resolve gastrointestinal bleeding and improve hemostatic parameters in a patient with Heyde's syndrome?
TAVI successfully treated Heyde's syndrome by correcting acquired von Willebrand factor type 2A deficiency and stopping gastrointestinal bleeding in a high-risk surgical patient.
Diagnosis of Heyde syndrome merits consideration in aortic stenosis with bleeding; case report leaves open TAVI role versus surgery.
Calcified aortic stenosis is the most common valvulopathy of the elderly. Its association with angiodysplasia and digestive bleeding is known as Heyde syndrome. This clinical case highlights the importance of the diagnosis of this syndrome whose complications can be fatal. The cessation of gastrointestinal bleeding is often remarkable after aortic valve replacement. Transcatheter aortic valve implantation (TAVI) can represents a good alternative to surgical valve replacement, especially in patients with high surgical risk. We report a case of 62-year-old patient, admitted for management of global cardiac decompensation on a tight aortic stenosis, confirmed by transthoracic echocardiography as well as a few episodes of syncope. He had a history of repeated lower digestive hemorrhages that required several transfusions. The evolution was marked by the appearance of heavy rectal bleeding on cecum angiodysplasia lesions confirmed by colonoscopy. The association of digestive bleeding and aortic stenosis raised the diagnosis of Heyde syndrome. An assay of von Willebrand factor (vWF) antigen, vWF binding collagen activity and their ratio confirmed a qualitative deficiency of vWF type 2A. The proposed treatment was TAVI because of the high surgical risk and the patient's refusal of the surgery. The evolution at 1 month post TAVI was marked by the improvement of hemostatic parameters related to the vWF and the disappearance of cardiac symptomatology. The cessation of gastrointestinal bleeding in Heyde's syndrome is conditioned by percutaneous aortic valve replacement in the high-risk surgical subject with a good clinical and biological evolution.
No takes yet. Share an insight, caveat, or question.
Choukri et al. (2022) conducted a case report in Heyde's Syndrome (n=1). Transcatheter aortic valve implantation (TAVI) was evaluated on Clinical and biological improvement (cessation of bleeding, vWF parameters). Transcatheter aortic valve implantation in a patient with Heyde's syndrome led to the normalization of von Willebrand factor parameters and complete cessation of gastrointestinal bleeding at 1 month.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: